Fully diluted it's 820M inc 150M options which represents cash inflow if they are exercised in the first instant, shares on issue which is the barometer used for most mrkt caps is 450M
They have been testing this thing as a private entity for a while already , they have stated Aust (TGA) and Europe approvals will come before USA (FDA) approval and that's in 2017.
With options linked to performance of commercial delivery , management will go sooner rather than later in the next 12 months to ensure their milestones are hit. They don't have to worry about pumping and then prolonging a story due to waiting on escrow stock like another stock in this space.
Oh and as for short term price predictions I am still waiting for the price to go down to the listing price of 2c as some predicted , sounds like a short supply of working crystal balls in the market place
EPT Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
